IBOTTA INC-CL A (IBTA) Stock Analyst Ratings
NYSE:IBTA - US4510511060 - Common Stock
25.47 USD
-0.12 (-0.47%)
25.97 USD
+0.5 (+1.96%)
ChartMill assigns a Buy % Consensus number of 76% to IBTA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.04. This target is 21.86% above the current price.
IBTA was analyzed by 15 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about IBTA.
In the previous month the buy percentage consensus was at a similar level.
IBTA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-08-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-14 | Needham | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-08-14 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-08-14 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-08-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-05-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-27 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-01-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-14 | UBS | Downgrade | Buy -> Neutral |
| 2024-11-14 | Needham | Maintains | Buy -> Buy |
| 2024-11-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-29 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-10-28 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-08-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-14 | Needham | Maintains | Buy -> Buy |
| 2024-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-14 | Evercore ISI Group | Maintains | Outperform -> Outperform |